全新SKINVIVE 光 目登 -- 引突破水光界限 - 新 - PChome Online 新

全新SKINVIVE 光 目登 -- 引突破水光界限

邂逅肌原生美肌 奢享光自由

按此下高清片:(https://bit.ly/446KV5I)

香港 2025年6月24日 /美通社/ -- 全球美容商 Allergan Aesthetics 引突破水光界限,隆重宣全新品牌SKINVIVE 登。此同,我也非常高宣著名演蔡思韵(Cecilia)成SKINVIVE 的品牌代言人,手揭秘峰美新作,呈您看得的、滑、亮1-2,活全方位的肌底「源」力,、光瑕!


全新SKINVIVE 光 目登 -- 引突破水光界限

全球美容品牌Allergan Aesthetics宣布著名演蔡思韵(Cecilia)成 SKINVIVE 光 的最新品牌代言人。

她一起肌源年 深透光肌

作影界的力派演,Cecilia 蔡思韵以特的和的表演方式,吸引了。清新俗的和她的雅恰好了SKINVIVE 肌原生之美的理念。

她而言,皮水份不足引起一串的肌,因此保是日常不可或缺。怪下的Cecilia每一都是高光透亮的,整天光彩照人! Cecilia亦深明保是全方位的,日常的食、健康生活固然重要,配合有效的美管理皆不能少。亦是 Cecilia 答任SKINVIVE 代言人的原因 ,而其品牌的3 大亮 高效可靠、 省、一次到位更是值得信!


全新SKINVIVE 光 目登 -- 引突破水光界限

蔡思韵(Cecilia)以其清新俗的,完美演 SKINVIVE 光 的原生美肌理念,其高效、省、一次到位的三大亮,值得信!

唯一得重 6大新生「肌」

SKINVIVE 第一及唯一得美FDA及盟CE重3-4的透明酸水光品牌,於法造,使用全球No.1品牌5Juvéderm 雅登 的利技6,保肌融合度佳6,效果更自然持久6

一般品的透明酸,大多只能皮表保7,而SKINVIVE 原健康健康而,其透明酸感薄7,能入肌底8-9深透肌真皮10*,根源10,平11,6大新生「肌」1,10 清透提亮§均色毛孔**,重拾健康水光感,您一同踏上原生光之旅。


全新SKINVIVE 光 目登 -- 引突破水光界限

SKINVIVE 光 是首且唯一得美FDA及盟CE重的透明酸水光品牌,法造用 Juvéderm 雅登 利技,保自然持久,六大新生「肌」。

唯一透明酸水光程最效果 繁步

造健康透亮的肌,必源始,由内而外活肌。SKINVIVE 能提升胞水通道(AQP3)12,放效^深*水之,水分水通道到表12,有助恢肌屏障功能及性活力13。科研一次持效9月10,14^,超96% 用家表示程後肌更滑,及光感提升了3倍意度,更意自己1。只需大10-15分15, 即可重拾健康肌,打好基。

全新SKINVIVE 重塑水光峰,肌由而外亮光。有程容及格,向各大原供的中心查。

於Allergan Aesthetics*

作全球美容商,Allergan Aesthetics致力於提供全面基於科研的品,以足用家的不同需要。我相信自信的力量,一直消者放在首位,藉多年在美域的深耕新探索,他做出理性的美,更加自信的人生。我恪守卓越的承,客提供的新品、培教育和服,向客信心。

媒查 :



Allergan Aesthetics

Ms Mabel Chan

mabel.chan@allergan.com

2610 5823

MAXLYTICS Limited

Ms Fiona Cheung

info@maxlytics.io

3709 2787

^Based on a search of published clinical studies of injectable HA treatments in March 2023. A duration of 9 months of skin hydration was established with SKINVIVE.11

* Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively).10

Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1,4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively) and top-up treatment administered at Day 30 (n=31). 10

§Lasting up to 9 months as reported by 63% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how radiant their facial skin looked.1

‖ Lasting up to 9 months as reported by 55.1% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how smooth their facial skin looked.1

**Lasting up to 9 months as reported by 55.9% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how their pores looked.1

Lasting up to 9 months as reported by 67.7% of patients. As reported by patients (127/131; 3 subjects did not respond) in a composite satisfaction score, which includes satisfaction with their skin's tone (colour).1

Lasting up to 9 months as reported by 64.6% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how clear their facial skin looked.1

Subjects completed the FACE-Q Satisfaction With Skin scale at baseline (Day 0, before treatment), Months 1, 4, 6, and 9 (before repeat treatment, if received), and Month 1 after the repeat treatment (n=131; n=62 received repeat treatment). The Satisfaction With Skin scale is a validated patient-reported outcome instrument designed to assess the impact of treatment from the subject's perspective. The scale comprises 12 questions about satisfaction with different facial skin attributes (e.g. smoothness, clearness, radiance). Responses are rated on a 4-point scale (1: very dissatisfied, 4: very satisfied). Scores for each item.1

References:
1. Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):10651070

2. Clin Cosmet Investig Dermatol. 2022 Mar 10;15:411426

3. SKINVIVE by Juvéderm is FDA approved. U.S. Food and Drug Administration, Department of Health & Human Services. SKINVIVE by Juvéderm approval letter P110033/S059, May 2023.

4. SKINVIVE by Juvéderm is CE approved. European Commission, hyaluronic acid based medical devices. EC certificate number: 3824296CE05

5. Allergan Aesthetics. Data on File. REF-108642. JUVDERM, the world's leading brand of hyaluronic acid facial fillers claim. Mar 2023.

6. Allergan Unpublished Data. INT-VOT-2050006. Juvederm VOLITE laboratory testing: hydration and elasticity, mouldability, tissue integration, spreadability. May 2020.

7. Purnamawati S et al. Clin Med Res. 2017;15(3-4);7587

8. Akinbiyi T et al. Plast Reconstr Surg Glob Open. 2020;8(10):e2763.

9. Lipko-Godlewska S et al. Clin Cosmet Investig Dermatol. 2021;14:169178.

10. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791798.

11. SKINVIVE by Juvéderm DFU. 20074348. Revision 2022.09.30.

12. Safa M et al. Clin Cosmet Investig Dermatol. 2022;15:411426.

13. Draelos Z. J Clin Aesthet Dermatol. 2012;5(7):5356.

14. Allergan Aesthetics. Unpublished data. SKINVIVE by JUVEDERM 9-month duration of skin hydration in clinical trials. March 2023.

15. Allergan Aesthetics. Unpublished data. SKINVIVE time of injection. REF-116636. October 2023.

SKINVIVE by Juvéderm (Hyaluronic Acid Gel with Lidocaine). All adverse events should be reported to MedDeviceComplaintsAPAC@abbvie.com.

Allergan Hong Kong Limited. 香港北角道 183 友邦 24 2404 室; : (852)26102525. 2025 Allergan Aesthetics. All rights reserved. HK-SKV-250035 | 20/MAY/25

Google新-PChome Online新


最新新
人新
行版
ubao snddm index pchome yahoo rakuten mypaper meadowduck bidyahoo youbao zxmzxm asda bnvcg cvbfg dfscv mmhjk xxddc yybgb zznbn ccubao uaitu acv GXCV ET GDG YH FG BCVB FJFH CBRE CBC GDG ET54 WRWR RWER WREW WRWER RWER SDG EW SF DSFSF fbbs ubao fhd dfg ewr dg df ewwr ewwr et ruyut utut dfg fgd gdfgt etg dfgt dfgd ert4 gd fgg wr 235 wer3 we vsdf sdf gdf ert xcv sdf rwer hfd dfg cvb rwf afb dfh jgh bmn lgh rty gfds cxv xcv xcs vdas fdf fgd cv sdf tert sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf sdf shasha9178 shasha9178 shasha9178 shasha9178 shasha9178 liflif2 liflif2 liflif2 liflif2 liflif2 liblib3 liblib3 liblib3 liblib3 liblib3 zhazha444 zhazha444 zhazha444 zhazha444 zhazha444 dende5 dende denden denden2 denden21 fenfen9 fenf619 fen619 fenfe9 fe619 sdf sdf sdf sdf sdf zhazh90 zhazh0 zhaa50 zha90 zh590 zho zhoz zhozh zhozho zhozho2 lislis lls95 lili95 lils5 liss9 sdf0ty987 sdft876 sdft9876 sdf09876 sd0t9876 sdf0ty98 sdf0976 sdf0ty986 sdf0ty96 sdf0t76 sdf0876 df0ty98 sf0t876 sd0ty76 sdy76 sdf76 sdf0t76 sdf0ty9 sdf0ty98 sdf0ty987 sdf0ty98 sdf6676 sdf876 sd876 sd876 sdf6 sdf6 sdf9876 sdf0t sdf06 sdf0ty9776 sdf0ty9776 sdf0ty76 sdf8876 sdf0t sd6 sdf06 s688876 sd688 sdf86